Kings Path Partners LLC decreased its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 38.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,590 shares of the company's stock after selling 8,550 shares during the quarter. Kings Path Partners LLC's holdings in Vital Farms were worth $414,000 at the end of the most recent reporting period.
Several other institutional investors also recently added to or reduced their stakes in VITL. Barclays PLC increased its stake in shares of Vital Farms by 57.3% in the third quarter. Barclays PLC now owns 95,444 shares of the company's stock worth $3,347,000 after buying an additional 34,758 shares during the period. Spire Wealth Management boosted its stake in Vital Farms by 66.2% in the 4th quarter. Spire Wealth Management now owns 11,800 shares of the company's stock worth $445,000 after purchasing an additional 4,700 shares in the last quarter. Values First Advisors Inc. bought a new position in Vital Farms in the 4th quarter worth about $199,000. Van ECK Associates Corp boosted its stake in Vital Farms by 112.8% in the 4th quarter. Van ECK Associates Corp now owns 5,579 shares of the company's stock worth $210,000 after purchasing an additional 2,957 shares in the last quarter. Finally, Vontobel Holding Ltd. bought a new position in Vital Farms in the 4th quarter worth about $298,000. Institutional investors own 98.59% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. DA Davidson reduced their price target on shares of Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a research report on Friday, March 14th. Morgan Stanley reduced their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a research note on Tuesday, May 6th. William Blair reiterated an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $52.00 target price on shares of Vital Farms in a research note on Monday, May 5th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $44.63.
View Our Latest Report on VITL
Vital Farms Stock Down 0.7%
Shares of NASDAQ VITL traded down $0.23 on Tuesday, hitting $31.23. The company had a trading volume of 192,103 shares, compared to its average volume of 1,026,162. Vital Farms, Inc. has a 12-month low of $27.91 and a 12-month high of $48.41. The business has a 50 day moving average of $33.37 and a two-hundred day moving average of $35.16. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.39 billion, a P/E ratio of 27.88 and a beta of 0.94.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.11. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The firm had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. During the same period last year, the company posted $0.43 EPS. The firm's quarterly revenue was up 9.7% on a year-over-year basis. As a group, equities research analysts forecast that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.
Insider Activity at Vital Farms
In other Vital Farms news, CEO Russell Diez-Canseco sold 45,124 shares of the business's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $33.69, for a total value of $1,520,227.56. Following the completion of the sale, the chief executive officer now owns 703,736 shares of the company's stock, valued at $23,708,865.84. The trade was a 6.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Matthew Ohayer sold 24,000 shares of the business's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $32.68, for a total value of $784,320.00. Following the completion of the sale, the insider now directly owns 6,942,890 shares of the company's stock, valued at $226,893,645.20. This represents a 0.34% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 93,124 shares of company stock valued at $3,019,308. Insiders own 27.60% of the company's stock.
Vital Farms Company Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Further Reading

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.